Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotic and vaginal probiotic treatment for genital mycoplasma-associated unexplained infertility
ACTRN12624001180505Phase 2Recruiting
- Sponsor
- The University of Western Australia
- Start
- Sep 2025
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of azithromycin, doxycycline, moxifloxacin and V-Spot Vaginal Probiotic Pessary in Unexplained infertility and Mycoplasma colonization (2 cohorts), sponsored by The University of Western Australia. Primary endpoint: Change in the rate of clinical pregnancy. Started Sep 2025; status: recruiting.
02
Drugs
azithromycindoxycyclinemoxifloxacinV-Spot Vaginal Probiotic Pessary
03
Conditions
Unexplained infertilityMycoplasma colonization
Beyond the preview
Go deeper on ACTRN12624001180505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12624001180505.